Search

everythinglearnresearchcommunity

for

Search:↓

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Psoriasis can cause temporary or permanent hair loss.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Some alternative treatments for hair loss might work, but more research is needed.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Marie Antoinette syndrome causes sudden hair whitening, but its exact cause is unknown.

Stronger corticosteroids cause more skin damage in hairless dogs, similar to effects in humans.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that recognizing oral lesions is important for diagnosing syphilis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.